• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ONCT

ONCT

Oncternal Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.53

-0.17 (-24.12%)

Company Profile

CEO

James B. Breitmeyer

IPO Date

2004-02-03

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.70

Prev. Close

$0.69

Day Low

$0.53

Day High

$0.70

52W Low

$0.53

52W High

$10.61

Market Cap

$0.00B

Volume

0.64M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

31.5%

Avg Negative

2.1%

Avg Neutral

66.3%

News Feed

Oncternal Therapeutics to Provide Business Update and Report Second Quarter 2021 Financial Results

GlobeNewsWire·7/29/2021·↑ positive

Oncternal Therapeutics Appoints Pablo Urbaneja as Sr. Vice President, Corporate Development

GlobeNewsWire·7/1/2021·↑ positive

Oncternal Therapeutics: New Data Continues To Derisk

Seeking Alpha·6/20/2021·↑ positive

Oncternal Therapeutics Reports Granting of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewsWire·6/1/2021·↑ positive

Oncternal Therapeutics (ONCT) Stock: Over 9% Increase Pre-Market Explanation

Pulse2·5/20/2021·↑ positive

Oncternal Therapeutics Presents Updated Interim Data for TK216 in Patients with Relapsed or Refractory Ewing Sarcoma in an Oral Session at ASCO 2021

GlobeNewsWire·5/19/2021·↑ positive

Oncternal Therapeutics Presents Updated Interim Data for Cirmtuzumab in Combination with Ibrutinib at ASCO 2021

GlobeNewsWire·5/19/2021·↑ positive

Oncternal Therapeutics, Inc. (ONCT) CEO Jim Breitmeyer on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/6/2021·↓ negative

Oncternal Therapeutics Announces Appointment of Chase Leavitt as General Counsel

GlobeNewsWire·4/12/2021·↑ positive

Oncternal Therapeutics Announces Presentation of Three Posters at AACR 2021 Virtual Meeting

GlobeNewsWire·4/12/2021·↑ positive